regenHU — a three dimensional biotechnology company, exploiting the potential of 3D bioprinting & cell based therapies — is leading the development of biomedical products for regenerative medicine & drug discovery. Based in Fribourg, Switzerland, regenHU is a pioneer and global leader in the field, converging digital manufacturing (3D printing), biomaterials and biotechnology to lead transformational innovations in Healthcare.
Value Proposition regenHU provides leading-edge 3D bioprinting solutions. R&D teams worldwide purchase regenHU’s bioprinting platforms and biomaterials because they provide the greatest flexibility and precision for tissue engineering – such as bone, muscle, tendon, skin, kidney, liver and lung. regenHU enables therapies that are biologically and structurally tailored to each patient’s needs. Step-by-step, these breakthroughs are revolutionizing regenerative medicine, drug discovery and cosmeceutical development.Which healthcare breakthroughs do you want to accomplish? Ask us how regenHU can help you make them happen!
RegenHU dedicates its engineering efforts on supporting the scientific community with cutting-edge bioprinting and biofabrication solutions to enable scientific advancements leading to the development of novel clinical products, therapies and solutions.
To date our bioprinting solutions are used for multidisciplinary applications, among other:
We will be delighted on supporting your activity with our expertise, passion & network.
regenHU Ltd has not received any reviews.
regenHU Ltd has not received any endorsements.